Elekta

Elekta develops precision radiation therapy systems and software for cancer care and the treatment of brain disorders. Its portfolio includes linear accelerators, MR-guided radiotherapy, treatment-planning software, brachytherapy and Leksell Gamma Knife systems. Adaptive radiotherapy enables care teams to adjust treatment to changes in a patient’s anatomy rather than relying solely on an initial plan.

Founded in 1972 and headquartered in Stockholm, Elekta has a UK operation in Crawley. Its 2025/26 annual report records 4,102 employees worldwide, including 652 in the UK, at the reporting year end. More than 2 million patients each year receive treatment using Elekta solutions across 130 countries. The company combines treatment delivery, imaging and software to support clinical workflows.